Evogliptin

Evogliptin

Cat Number
API1222102295
CAS Number
1222102-29-5

For research use only. We do not supply to patients.

For pharmaceutical-grade products or other inquiries, please contact our experts.

CAS Number
1222102-29-5
Description
Evogliptin (DA-1229) is a DPP4 inhibitor with oral activity. Evogliptin has significant and lasting hypoglycemic effect in mouse model. Evogliptin inhibits the production of the fibrosis and inflammatory in hepatocytes signals by inducing autophagy. Evogliptin can be used to study type 2 diabetes, chronic liver inflammation, osteoporosis and renal impairment.
Molecular Formula
C19H26F3N3O3
Molecular Weight
401.42
You Might Also Like
Imiquimod
Imiquimod

Cat NO.: API0232224
CAS NO.: 99011-02-6

View Details
Revumenib
Revumenib

Cat NO.: API2169919213
CAS NO.: 2169919-21-3

View Details
Crotamiton
Crotamiton

Cat NO.: API483636
CAS NO.: 483-63-6

View Details
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide

Cat NO.: API1621369730
CAS NO.: 1621369-73-0

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)

All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.

Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.


WhatsAPP
Top